BQST — Bioquest Share Price
Last trade - 00:00- $0.46m
- $0.55m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 30th Apr | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bioquest Corp. markets, packages, and distributes health Hemp-Cannabidiol (CBD) based products. The Company is focused on bringing men’s, women’s, lifestyle, and pet products that are (CBD) based products to the marketplace. The Company's products are branded under the Vital-Q name. Its products include Age Refining Serum- Sculping Formula Plus CBD, Royal Q - CBD infused Majestic Body Cream, Responsive Formula - Collagen Retinol Anti-Aging Cream plus CBD, Age Defying Skin Cream- Apple Stem Cell Plus CBD, and others. In addition to its existing product line of women’s products, it is also developing products, which contain both non-CBD and CBD ingredients that are derived from hemp. The Company's products are sold primarily into the business-to-business market and Internet-based business-to-consumer, which includes legally operating medical and adult-use dispensaries, store fronts, and brand owners in states with CBD programs.
Directors
- Thomas Hemingway CHM (65)
- Michael Krall PRE (69)
- David Noyes CFO (78)
- Jeffery Donnell EVP (70)
- Pamela Daily CMO (70)
- Robert Orbach IND (67)
- Last Annual
- April 30th, 2021
- Last Interim
- January 31st, 2022
- Incorporated
- May 17th, 2011
- Public Since
- September 26th, 2013
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 11,395,230
- Address
- 4570 CAMPUS DRIVE #23, NEWPORT BEACH, NEWPORT BEACH, 92660
- Web
- https://www.bioquestcorp.com/
- Phone
- +1 4182647134
- Auditors
- ZBS Group LLP
Upcoming Events for BQST
Similar to BQST
Acacia Diversified Holdings
Pink Sheets on Nasdaq
Acusphere
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Aida Pharmaceuticals
Pink Sheets on Nasdaq
Allied
Pink Sheets on Nasdaq
FAQ
As of Today at 13:03 UTC, shares in Bioquest are trading at $0.04. This share price information is delayed by 15 minutes.
Shares in Bioquest last closed at $0.04 and the price had moved by -96.77% over the past 365 days. In terms of relative price strength the Bioquest share price has underperformed the S&P500 Index by -96.06% over the past year.
There is no consensus recommendation for this security.
Bioquest does not currently pay a dividend.
Bioquest does not currently pay a dividend.
Bioquest does not currently pay a dividend.
To buy shares in Bioquest you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.04, shares in Bioquest had a market capitalisation of $0.46m.
Here are the trading details for Bioquest:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: BQST
Based on an overall assessment of its quality, value and momentum Bioquest is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioquest. Over the past six months, its share price has underperformed the S&P500 Index by -90.18%.
As of the last closing price of $0.04, shares in Bioquest were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bioquest PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Bioquest's management team is headed by:
- Thomas Hemingway - CHM
- Michael Krall - PRE
- David Noyes - CFO
- Jeffery Donnell - EVP
- Pamela Daily - CMO
- Robert Orbach - IND